Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model

Recent in vitro and murine in vivo studies have identified several potential LPS tolerance factors. In this study, we describe the expression kinetics of these LPS tolerance factors in standardized human endotoxemia models using i.v. LPS bolus administration. Responsiveness to LPS as well as the expression of potential regulators of LPS signaling were determined in peripheral whole blood. Intravenous LPS administration (4 ng/kg) resulted in peak plasma levels of TNF-α at 1.5 h followed by subsequent peaks of the classic negative feedback inhibitors A20 and IL-10 at 2 and 3 h, respectively. Circulating blood monocyte counts decimated during the initial inflammatory response, but normalized in the period between 4 and 8 h post-LPS. The LPS response as determined by ex vivo TNF release per monocyte in whole blood was profoundly decreased at 6–8 h post-LPS injection despite cessation of A20 and IL-10 expression after 4 h. Analysis of MyD88short, IL-1R-associated kinase (IRAK)-1, IRAK-M, ST2, suppressor of cytokine signaling-1 and -3, SHIP-1, and MAP kinase phosphatase-1 expression indicated that the observed LPS tolerance was associated with decreased IRAK-1 and elevated IRAK-M expression in this human model. Interestingly, a lower dose of LPS (1 ng/kg) induced LPS tolerance accompanied with IRAK-M up-regulation but without depletion of IRAK-1. In vitro studies in whole blood showed that IRAK-M up-regulation by LPS is largely dependent on TNF-α. The observed rise of IRAK-M transcription in the human endotoxemia model appeared much greater compared with in vitro-stimulated whole blood. In conclusion, LPS tolerance in human endotoxemia models is associated with IRAK-M up-regulation.

[1]  G. Krystal,et al.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance. , 2004, Immunity.

[2]  J. Haas,et al.  Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. , 1994, The Journal of biological chemistry.

[3]  S. Endres,et al.  Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. , 1993, Biochemical and biophysical research communications.

[4]  R. Bone,et al.  Immunologic Dissonance: A Continuing Evolution in Our Understanding of the Systemic Inflammatory Response Syndrome (SIRS) and the Multiple Organ Dysfunction Syndrome (MODS) , 1996, Annals of Internal Medicine.

[5]  H. Wong,et al.  CONTRIBUTION OF MKP-1 REGULATION OF p38 TO ENDOTOXIN TOLERANCE , 2005, Shock.

[6]  M. Cassatella.  The production of cytokines by polymorphonuclear neutrophils. , 1995, Immunology today.

[7]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[8]  Paul J Hertzog,et al.  Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation , 2006, Nature Immunology.

[9]  F. Schildberg,et al.  Downregulation of proinflammatory cytokine release in whole blood from septic patients. , 1995, Blood.

[10]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[11]  S. Akira,et al.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages , 2003, Nature Immunology.

[12]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[13]  T. van der Poll,et al.  IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans1 , 2001, The Journal of Immunology.

[14]  B. Foxwell,et al.  Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human Macrophages , 2004, The Journal of Immunology.

[15]  F. Liew,et al.  ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance , 2004, Nature Immunology.

[16]  H. Chi,et al.  Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Kenji Nakanishi,et al.  SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.

[18]  Jiahuai Han,et al.  Limiting inflammatory responses during activation of innate immunity , 2005, Nature Immunology.

[19]  M. Karin,et al.  Immunity by ubiquitylation: a reversible process of modification , 2005, Nature Reviews Immunology.

[20]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[21]  T. Standiford,et al.  Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. , 2006, The Journal of clinical investigation.

[22]  Xiaomei Meng,et al.  MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock , 2006, The Journal of experimental medicine.

[23]  K. Heeg,et al.  Suppressor of Cytokine Signaling (SOCS) Proteins Indirectly Regulate Toll-like Receptor Signaling in Innate Immune Cells*♦ , 2004, Journal of Biological Chemistry.

[24]  S. Lowry,et al.  HUMAN ENDOTOXEMIA: A MODEL FOR MECHANISTIC INSIGHT AND THERAPEUTIC TARGETING , 2005, Shock.

[25]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[26]  R. Zamora,et al.  Nitric oxide activates the expression of IRAK-M via the release of TNF-α in human monocytes , 2004 .

[27]  K. Tracey,et al.  Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. , 1989, Annals of surgery.

[28]  J. Cavaillon,et al.  NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. , 2000, American journal of respiratory and critical care medicine.

[29]  C. Dinarello.  Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.

[30]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. McCarron,et al.  Septic Shock , 1964, International anesthesiology clinics.

[32]  Peter A. Ward,et al.  Novel strategies for the treatment of sepsis , 2003, Nature Medicine.

[33]  G. Stark,et al.  IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.

[34]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[35]  C. del Fresno,et al.  Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. , 2003, Biochemical and biophysical research communications.

[36]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[37]  T. van der Poll,et al.  UvA-DARE ( Digital Academic Repository ) Diminished interferon-gamma production and responsiveness after endotoxin administration to healthy humans , 2002 .

[38]  P. Majerus,et al.  Multiple forms of the SH2-containing inositol phosphatase, SHIP, are generated by C-terminal truncation. , 1998, Blood.

[39]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[40]  A. Hobbs,et al.  Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice , 2005, Journal of Biological Chemistry.

[41]  J. Mages,et al.  Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock , 2006, The Journal of experimental medicine.

[42]  Ki-Young Lee,et al.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. , 2005, Genes & development.

[43]  Peter J Munson,et al.  Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. , 2006, Physiological genomics.

[44]  K. Rajewsky,et al.  Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. , 1995, The Journal of clinical investigation.

[45]  J. E. Doran,et al.  Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia , 1996, The Journal of experimental medicine.

[46]  L. Ziegler‐Heitbrock,et al.  Tolerance Induced by the Lipopeptide Pam3Cys Is Due to Ablation of IL-1R-Associated Kinase-11 , 2004, The Journal of Immunology.

[47]  C. Chung,et al.  Sepsis‐induced SOCS‐3 expression is immunologically restricted to phagocytes , 2003, Journal of leukocyte biology.

[48]  S. Akira,et al.  Interleukin-10 Receptor Signaling through the JAK-STAT Pathway , 1999, The Journal of Biological Chemistry.

[49]  P. Reitsma,et al.  Treatment with an Anti-CD14 Monoclonal Antibody Delays and Inhibits Lipopolysaccharide-Induced Gene Expression in Humans in Vivo , 2003, Journal of Clinical Immunology.

[50]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.

[51]  T. van der Poll,et al.  Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. , 1996, The Journal of infectious diseases.

[52]  D. Golenbock,et al.  Dysregulation of LPS-Induced Toll-Like Receptor 4-MyD88 Complex Formation and IL-1 Receptor-Associated Kinase 1 Activation in Endotoxin-Tolerant Cells1 , 2002, The Journal of Immunology.

[53]  K. Kreuzer,et al.  Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. , 2002, Molecular and cellular probes.